🇺🇸 FDA
Patent

US 7332469

Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

granted A61KA61K38/49

Quick answer

US patent 7332469 (Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions) held by The Board of Regents of the University of Texas System expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/49